Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27

被引:1
作者
Uneda, Shima [1 ]
Gotoh, Minako [2 ]
Sonoki, Takashi [1 ]
Nishida, Kazuhiro [2 ]
Nakamura, Yasushi [3 ]
Kurimoto, Miwa [1 ]
Hanaoka, Nobuyoshi [1 ]
Matsuoka, Hiroshi [1 ]
Taniwaki, Masafumi [2 ]
Nakakuma, Hideki [1 ]
机构
[1] Wakayama Med Univ, Dept Hematol Oncol, Wakayama 6418510, Japan
[2] Kyoto Prefectural Univ Med, Dept Hematol & Oncol, Kyoto, Japan
[3] Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Japan
关键词
Lymphoma; CD5; CD10; Translocation; 8q24; 6q27;
D O I
10.1007/s12185-008-0189-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We established a novel mature B-cell line from a CD5 and CD10 double-positive diffuse large B-cell lymphoma patient, designated as WILL1. WILL1 cells were positive for CD5, CD10, CD19, and CD20. Spectral karyotype (SKY) analysis revealed chromosome 8 signals on 6q27 as well as 14q32. Fluorescence in situ hybridization (FISH) analysis suggested that a translocation break occurred outside the immunoglobulin heavy chain (IGH) gene on 14q32. Moreover, fusion signals of IGH and C-MYC probes were detected on the derivative 6 and derivative 14 chromosomes. Southern blot analysis using a C-MYC exon II fragment failed to detect rearrangement, suggesting that the 8q24 breakpoints lay far up- or downstream of the C-MYC gene. WILL1 is a useful tool to analyze the pathogenesis of CD5 and CD10 double-positive diffuse large B-cell lymphoma, and for molecular cloning of the unique translocation breakpoints of 14q32 and 8q24 and a novel gene on 6q27.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 34 条
  • [1] Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene
    Akasaka, T
    Akasaka, H
    Ueda, C
    Yonetani, N
    Maesako, Y
    Shimizu, A
    Yamabe, H
    Fukuhara, S
    Uchiyama, T
    Ohno, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 510 - 518
  • [2] Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
    Bergsagel, PL
    Chesi, M
    Nardini, E
    Brents, LA
    Kirby, SL
    Kuehl, WM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13931 - 13936
  • [3] Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas
    Bertrand, P.
    Bastard, C.
    Maingonnat, C.
    Jardin, F.
    Maisonneuve, C.
    Courel, M-N
    Ruminy, P.
    Picquenot, J-M
    Tilly, H.
    [J]. LEUKEMIA, 2007, 21 (03) : 515 - 523
  • [4] Flow cytometric immunophenotyping for hematologic neoplasms
    Craig, Fiona E.
    Foon, Kenneth A.
    [J]. BLOOD, 2008, 111 (08) : 3941 - 3967
  • [5] Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011
  • [6] B-cell lymphomas with coexpression of CD5 and CD10
    Dong, HY
    Gorczyca, W
    Liu, Z
    Tsang, P
    Wu, CD
    Cohen, P
    Weisberger, J
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (02) : 218 - 230
  • [7] Dyer MJS, 1996, LEUKEMIA, V10, P1198
  • [8] t(6;14)(q15;q32) in a patient with CD5+CD10+diffuse large B-Cell lymphoma
    Hayama, Miyuki
    Niitsu, Nozomi
    Higashihara, Masaaki
    Nakamine, Hirokazu
    Miura, Ikuo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (02) : 147 - 149
  • [9] Molecular biology of Burkitt's lymphoma
    Hecht, JL
    Aster, JC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3707 - 3721
  • [10] VARIABLE BREAKPOINTS IN BURKITT-LYMPHOMA CELLS WITH CHROMOSOMAL T(8-14) TRANSLOCATION SEPARATE C-MYC AND THE IGH LOCUS UP TO SEVERAL 100 KB
    JOOS, S
    FALK, MH
    LICHTER, P
    HALUSKA, FG
    HENGLEIN, B
    LENOIR, GM
    BORNKAMM, GW
    [J]. HUMAN MOLECULAR GENETICS, 1992, 1 (08) : 625 - 632